Strainsforpains, Inc. Announces Corporate Update (NY, NY)-(July 11, 2023)-(Strainsforpains, Inc.)(OTC Markets : EBYH). The company is glad to update its shareholders as to recent progress. In June 2023, Mr. Shainberg , CEO of Strainsforpains, signed collaborative agreements with esteemed health, wellness, and cannabis companies at the Toronto 33rd International Cannabis Research Society Symposium. We are also excited to announce that our health products will be developed and made available through reputable dispensaries including Columbia Care dispensaries. Our focus is partnering with dispensaries that have a strong brand reputation for delivering high-quality products to their customers. These products, including our premium CBD offerings, will be manufactured and distributed across various locations, including our facility in Pennsylvania. They will feature vegan and gluten-free ingredients, ensuring quality and accessibility. Furthermore, we are actively engaged in sharing data and collaborating with major health companies, including Teva Pharmaceuticals, as well as organizations possessing advanced technological and clinical expertise. We aim to pursue valuable opportunities that align with our vision. In the upcoming months, we anticipate signing a long-term lease with regional companies, including a cryptocurrency mining company. Terawulf, a Bitcoin miner located 1.5 miles from our facility, is among them. Additionally, we are working with our engineers to enhance our Pennsylvania site by incorporating up to 20 tons of cannabis storage capacity, in collaboration with a farming collective in South Western Virginia. The lease announcement is scheduled for August 2023. Our Pennsylvania property’s strategic location and ample space offer immense value, catering to both tech and storage requirements and supporting the growth of businesses. Mr. Shainberg of Strainsforpains, expressed his enthusiasm, stating, "We are delighted to collaborate with exceptional companies. By leasing our Pennsylvania space, engaging in research partnerships, and securing health product placements, we will generate significant additional revenue, expand our presence in the health product market, and access a new customer base."
